ResearcherDartmouth CollegeNo recent work listed
Ana S. Leal
Matched on ORCID iD 0000-0001-6472-2879; OpenAlex author ID A5021395533. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper
Papers 6
- The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Co-author DOI 10.3390/cancers13010096↗
- Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. Co-author DOI 10.1002/cpph.48↗
- Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1. First author DOI 10.1038/s41598-018-34131-1↗
- Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.02.021↗
- The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer. Co-author DOI 10.1093/carcin/bgw099↗
- Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic canc… Co-author DOI 10.1016/j.bmc.2012.08.010↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karen T. Liby · 5 shared papers, 2016–2020 · strength 0.59
- Paper Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. DOI 10.1002/cpph.48↗
- Paper The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Mode… DOI 10.3390/cancers13010096↗
- Paper Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of… DOI 10.1038/s41598-018-34131-1↗
- Michael B. Sporn · 2 shared papers, 2016–2017 · strength 0.17
- Vânia M. Moreira · 1 shared paper, 2018 · strength 0.11
- Laura E. Kolsi · 1 shared paper, 2018 · strength 0.11
- Yongkui Jing · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.